Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 2, 2006, Pages 301-305

  Rouse, Mark S ^a   Piper, Kerryl E ^a   Jacobson, Melissa ^a   Jacofsky, David J ^a   Steckelberg, James M ^a   Patel, Robin ^a  

^a Mayo Clinic   (United States)

Author keywords

Polymethylmethacrylate; Rats; Vancomycin

Indexed keywords

DAPTOMYCIN; POLY(METHYL METHACRYLATE); VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; BIOMECHANICS; CHRONIC OSTEOMYELITIS; COMPRESSIVE STRENGTH; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RELEASE; IN VIVO STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RAT; STAPHYLOCOCCUS INFECTION; TENSILE STRENGTH; TIBIA;

ANIMALS; ANTI-BACTERIAL AGENTS; CHEMISTRY, PHARMACEUTICAL; CHRONIC DISEASE; DAPTOMYCIN; EXCIPIENTS; HARDNESS TESTS; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; OSTEOMYELITIS; POLYMETHYL METHACRYLATE; RATS; RATS, WISTAR; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 31544451594     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dki435     Document Type: Article

References (16)

1. Lew DP, Waldvogel FA. Osteomyelitis. N Engl J Med 1997; 336: 999-1007.
2. Solky BA, Pincus L, Horan RF. Vancomycin-induced linear IgA bullous dermatosis: Morphology is a key to diagnosis. Cutis 2004; 73: 65-7.
3. Schriever CA, Fernandez C, Rodvold KA et al. Daptomycin: A novel cyclic lipopeptide antimicrobial. Am J Health Syst Pharm 2005; 62: 1145-58.
4. Hanssen AD, Spangehl MJ. Practical applications of antibiotic-loaded bone cement for treatment of infected joint replacements. Clin Orthop 2004; 1: 79-85.
5. Hall EW, Rouse MS, Jacofsky DJ et al. Release of daptomycin from polymethylmethacrylate beads in a continuous flow chamber. Diagn Microbiol Infect Dis 2004; 50: 261-5.
6. Center for Devices and Neurological Health. Class II Special Controls Guidance Document: Polymethylmethacrylate (PMMA) Bone Cement; Guidance for Industry and FDA. Rockville, MD: U.S. Dept of Health and Human Services, 2002: 1-16.
7. International Organization for Standardization. Implants of Surgery - Acrylic Resin Cements. Geneva: ISO, 2002: 1-15.
8. Patel R, Piper KE, Rouse MS et al. Linezolid therapy of Staphylococcus aureus experimental osteomyelitis. Antimicrob Agents Chemother 2000; 44: 3438-40.
9. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Sixth Edition: Approved Standard M07-A6. CLSI, Villanova, PA, USA, 2003.
10. Luu QN, Buxton TB, Nelson DR et al. Treatment of chronic experimental Staphylococcus aureus osteomyelitis with LY146032 and vancomycin. Eur J Clin Microbiol Infect Dis 1989; 8: 562-3.
11. Vaudaux P, Francois P, Bisognano C et al. Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus. J Antimicrob Chemother 2003; 52: 89-95.
12. Safdar N, Andes D, Craig WA. In vivo pharmacodynamic activity of daptomycin. Antimicrob Agents Chemother 2004; 48: 63-8.
13. Dvorchik BH, Brazier D, DeBruin MF et al. Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects. Antimicrob Agents Chemother 2003; 47: 1318-23.
14. Mader JT, Adams K. Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits. Antimicrob Agents Chemother 1989; 33: 689-92.
15. Perry AC, Rouse MS, Khaliq Y et al. Antimicrobial release kinetics from polymethylmethacrylate in a novel continuous flow chamber. Clin Orthop Relat Res 2002; 403: 49-53.
16. Liu SJ, Wen-Neng Ueng S, Lin SS et al. In vivo release of vancomycin from biodegradable beads. J Biomed Mater Res 2002; 63: 807-13.